002773 On Other Exchanges
Symbol
Exchange
Shenzhen

chengdu kanghong pharmaceu-a (002773) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CHENGDU KANGHONG PHARMACEU-A (002773)
\

Related News

No related news articles were found.

chengdu kanghong pharmaceu-a (002773) Related Businessweek News

No Related Businessweek News Found

chengdu kanghong pharmaceu-a (002773) Details

Chengdu Kanghong Pharmaceuticals Group Co., Ltd engages in the research and development, production, and sale of Chinese medicines, chemical drugs, and biological products in China. Its products include central nervous system, digestive system, ophthalmic system, and other system drugs. The company was founded in 1996 and is headquartered in Chengdu, China.

4,382 Employees
Last Reported Date: 04/28/19
Founded in 1996

chengdu kanghong pharmaceu-a (002773) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

chengdu kanghong pharmaceu-a
Chengdu Kanghong Pharmaceuticals Group Co. Ltd. Approves Final Dividend for 2018, Payable Date June 06, 2019

Chengdu Kanghong Pharmaceuticals Group Co. Ltd. approved final dividend (tax included) of CNY 2.80000000 per 10 shares for 2018. Record date: 05 June 2019, Ex- date June 06, 2019 and Payable date June 06, 2019.

Chengdu Kanghong Pharmaceuticals Group Co. Ltd. Approves Final Dividend for 2018; Amends Articles of Association

Chengdu Kanghong Pharmaceuticals Group Co. Ltd. approved final dividend (tax included) of CNY 2.80000000 per 10 shares for 2018. The company also approved the amendments to the company's articles of association.

Chengdu Kanghong Pharmaceuticals Group Co., Ltd Proposes Amendments Articles of Association

Chengdu Kanghong Pharmaceuticals Group Co. Ltd. will hold the 2018 Annual General Meeting on 20 May 2019. At the meeting the company will propose amendments to the company's articles of association.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

002773 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002773.
View Industry Companies
 

Industry Analysis

002773

Industry Average

Valuation 002773 Industry Range
Price/Earnings 41.8x
Price/Sales 10.1x
Price/Book 6.8x
Price/Cash Flow 41.9x
TEV/Sales 9.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CHENGDU KANGHONG PHARMACEU-A, please visit www.cnkh.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.